Fingerprint
Dive into the research topics of 'Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically